Harry Alexopoulos

Athens, ESYE31 15701, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Journal: Brain sciences
Published: April 03, 2026

Regional astrocyte dysregulation and altered glymphatic-related markers in Alzheimer's disease frontal cortex.

Regional astrocyte dysregulation and altered glymphatic-related markers in Alzheimer's disease frontal cortex.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 26, 2026

Proteomic Analysis of Cerebrospinal Fluid from Severe COVID-19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome.

Proteomic Analysis of Cerebrospinal Fluid from Severe COVID-19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome.

Journal: Proteomics. Clinical applications
Published: May 06, 2025

CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy.

CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy.

Journal: Frontiers in immunology
Published: April 01, 2025

Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and KLK10-Gene Variants.

Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and KLK10-Gene Variants.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 11, 2025

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors.

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors.

Journal: Biomedicines
Published: April 29, 2024

Serological testing for SARS-CoV-2: Advancements and future challenges.

Serological testing for SARS-CoV-2: Advancements and future challenges.

Journal: European journal of internal medicine
Published: December 21, 2022

Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic Review.

Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic Review.

Journal: Biomedicines
Published: August 19, 2022

COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns.

COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns.

Journal: Trends in molecular medicine
Published: July 28, 2022

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies.

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies.

Journal: European journal of internal medicine
Published: July 25, 2022

Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy.

Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy.

Journal: HemaSphere
Published: June 18, 2022

Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals.

Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals.

Journal: HemaSphere
Published: May 17, 2022
Showing 1-12 of 40

Last Updated: 09/26/2026